The Global Program Head (GPH) for Oncology leads integrated strategy and execution for one or more REGN oncology antibody programs from lead selection through Biologics License Application (BLA). The GPH co-leads the asset strategic team with a clinical co-leader, aligns cross-functional stakeholders, and ensures Executive Management has the right information to authorize program strategy decisions. This role spans discovery through late-stage development and interfaces broadly across research, development, and commercial functions to deliver high-quality, scientifically rigorous, and competitive development plans.

**Key Responsibilities**

+ Drive creation and continuous refinement of an integrated, end-to-end program strategy from discovery through late-stage development and BLA submission
+ Co-lead the asset strategic team with the clinical co-leader; provide program oversight, execution discipline, and risk/issue management
+ Identify, engage, and align key s...